Sep 232026 In vivo CRISPR screens identify the glutamine transporter SLC1A5 as a metabolic barrier to antitumor immunity Sci. Immunol. 11, eaea4179 (2026). DOI:10.1126/sciimmunol.aea4179 Select the format you want to export the citation of this publication.
